{"metadata": {"source": "psychonaut", "title": "Fentanyl - PsychonautWiki", "description": "Fentanyl (also known as Fentanil and by the brand names Sublimaze,[2] Actiq, Durogesic, Duragesic, Fentora, Matrifen, Haldid, Onsolis, Instanyl,[3] Abstral,[4] Lazanda[5] among others[6]) is a potent opioid substance of the anilidopiperidine class. It is a strong agonist at the μ-opioid receptors and approximately 40 to 50 times more potent than pharmaceutical grade (i.e. 100% pure) heroin[7][8] and roughly 80 to 100 times more potent than morphine.&#91;citation needed&#93;", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Fentanyl", "drug": "Fentanyl", "cid": 3345, "char_count": 24990, "word_count": 3519, "doc_id": "doc_75", "num_chunks": 35, "chunk_id": "75::chunk_31", "document_index": 75, "latency_s": 0.7547820000036154, "prompt_toks": 6422, "completion_toks": 64, "relevance_score": 3.9442588e-05}, "content": "Drug: Fentanyl | cid: 3345\nSource: psychonaut | Source description: Fentanyl (also known as Fentanil and by the brand names Sublimaze,[2] Actiq, Durogesic, Duragesic, Fentora, Matrifen, Haldid, Onsolis, Instanyl,[3] Abstral,[4] Lazanda[5] among others[6]) is a potent opioid substance of the anilidopiperidine class. It is a strong agonist at the μ-opioid receptors and approximately 40 to 50 times more potent than pharmaceutical grade (i.e. 100% pure) heroin[7][8] and roughly 80 to 100 times more potent than morphine.&#91;citation needed&#93;\n\n                    Text: \n                    ↑ FENTANYL AND ANALOGUES | http://livertox.nih.gov/FentanylAndAnalogues.htm\n\n↑ Subsys (fentanyl sublingual spray), CenterWatch\n\n↑ INSYS Therapeutics Inc (2013), Open-label Multi-center Safety Trial of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain, clinicaltrials.gov\n\n↑ Narcotic Drugs Report 2014, UN | https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2014/Narcotic_Drugs_Report_2014.pdf\n\n↑ DEA: Deaths from fentanyl-laced heroin surging\n\n↑ Sidner, R. E., Sara (2016), Prince died of accidental overdose of opioid fentanyl, medical examiner says\n\n↑ Larsen, Rikke H.; Nielsen, Flemming; Sorensen, Jens A.; Nielsen, Jesper B. (2003). \"Dermal Penetration of Fentanyl: Inter- and Intraindividual Variations\". Pharmacology and Toxicology. 93 (5): 244–248. doi:10.1046/j.1600-0773.2003.pto930508.x. ISSN 0901-9928.\n\n\n                    Context: \n                    This excerpt provides references and sources related to fentanyl, including toxicity reports, overdose data, dermal penetration studies, and adverse event reports, supporting the document's detailed coverage of fentanyl's risks, pharmacology, and safety considerations. It emphasizes the substance's potency, overdose potential, and the importance of harm reduction.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Fentanyl (China White) Vault", "description": "Information about Fentanyl including uses, images, dosage, effects, legal status, and links to other resources.", "language": "No language found.", "url": "https://www.erowid.org/pharms/fentanyl/fentanyl.shtml", "drug": "Fentanyl", "cid": 3345, "substance": "fentanyl", "category": "PHARMS", "erowid_column": "MainPage", "char_count": 5913, "word_count": 824, "doc_id": "doc_106", "num_chunks": 8, "chunk_id": "106::chunk_6", "document_index": 106, "latency_s": 0.8765293000033125, "prompt_toks": 2026, "completion_toks": 78, "relevance_score": 1.9333584e-06}, "content": "Drug: Fentanyl | cid: 3345\nSource: erowid | Source description: Information about Fentanyl including uses, images, dosage, effects, legal status, and links to other resources.\nErowid name: fentanyl\nCategory: PHARMS\nField: MainPage\n\n                    Text: \n                    Injured US Marines to get 'lollipop' instead of morphine, Nov 1 2011, Telegraph.co.uk\n\nFentanyl timeline: 1950 through today, Jun 2007, Detroit Free Press\n\nLollipops & Lawsuits, May 2007, Newsweek\n\nDrug-patch safety triggers an FDA probe, Mar 2006, Philadelphia Inquirer\n\nFDA Slow to Sound Alarm on Pain Drug - Nov 2005, LA Times\n\nDrugPolicyCentral: Fentanyl News\n\nGOVERNMENT RESOURCES #\n\nfentanyl's increasing flows fuel steep rise in overdose deaths - UNODC, Mar 2017\n\nPharmaceutical Executives Charged in Racketeering Scheme - DOJ, Dec 8, 2016\n\nIncreases in Fentanyl Drug Confiscations and Fentanyl-related Overdose Fatalities - CDC, Oct 26, 2015\n\nDEA Issues Nationwide Alert on Fentanyl as Threat to Health and Public Safety, Mar 28 2015\n\nFDA approved fentanyl oral transmucosal tablets, Jan 7 2011\n\nFentanyl Patch Recall, Mar 1 2008\n\nFDA Publishes Letter by Manufacturer about Death from Buccal Product Fentora, Sep 10 2007\n\nU.S. DOJ Situation Report: Fentanyl (June 2006)\n\n\n                    Context: \n                    This chunk provides a timeline of significant events and news related to fentanyl from 2005 to 2017, including FDA actions, government reports, and media coverage, and is situated within the broader 'Fentanyl' page of the Erowid 'Pharms' vault. It offers key historical and regulatory milestones relevant to understanding fentanyl's impact, safety concerns, and legal developments.\n                "}
{"metadata": {"source": "pubchem", "title": "Fentanyl | C22H28N2O | CID 3345 - PubChem", "description": "Fentanyl | C22H28N2O | CID 3345 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3345", "drug": "Fentanyl", "cid": 3345, "char_count": 196495, "word_count": 26843, "doc_id": "doc_16", "num_chunks": 282, "chunk_id": "16::chunk_98", "document_index": 16, "latency_s": 1.3506922999949893, "prompt_toks": 49738, "completion_toks": 105, "relevance_score": 1.6280515e-06}, "content": "Drug: Fentanyl | cid: 3345\nSource: pubchem | Source description: Fentanyl | C22H28N2O | CID 3345 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Brand or Generic Form (Manufacturer)\n\nFentora, C-II (Teva)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nTablet\n\nStrength\n\n400 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nFentora, C-II (Teva) repackager by generic (nonproprietary) name)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nTablet\n\nStrength\n\n600 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nFentora, C-II (Teva)\n\nRoute of Administration\n\nBuccal (Transmucosal)\n\nDosage Form\n\nTablet\n\nStrength\n\n800 ug (of fentanyl)\n\nBrand or Generic Form (Manufacturer)\n\nFentora, C-II (Teva)\n\nRoute of Administration\n\nNasal\n\nDosage Form\n\nSolution\n\nStrength\n\n100 ug (of fentanyl) per metered spray\n\nBrand or Generic Form (Manufacturer)\n\nLazanda, C-II; with carbon-lined disposal pouch (Depomed)\n\nRoute of Administration\n\nNasal\n\nDosage Form\n\nSolution\n\nStrength\n\n300 ug (of fentanyl) per metered spray\n\nBrand or Generic Form (Manufacturer)\n\nLazanda, C-II; with carbon-lined disposal pouch (Depomed)\n\n\n                    Context: \n                    This excerpt details specific formulations and strengths of Fentanyl-based medications marketed under the brand Fentora by Teva, including oral tablets at various dosages and nasal spray solutions, with manufacturer and packaging details. It is part of the comprehensive pharmacological and formulation information provided in the full document, aiding precise identification and dosing references for Fentanyl formulations. These data are crucial for understanding available prescription forms, routes of administration, and dosage strengths within the broader context of Fentanyl's medical use, safety profiles, and regulatory information.\n                "}
